QMS Medical Allied Services growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
+10.8%
+1.9%
+1.7%
−13.0%
−20.2%
+12.1%
−3.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

QMSMEDI₹177.18

QMS Medical Allied Services Limited

· Pharma & Health
₹ CroreMcap ₹343 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—+10.8—
EBITDA Growth—+1.9—
EBIT Growth—+1.7—
Net Income Growth—-13.0—
EPS Growth—-20.2—
Total Assets Growth—+12.1—
Cash from Operations Growth—-3.4—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.